Know more

Our use of cookies

Cookies are a set of data stored on a user’s device when the user browses a web site. The data is in a file containing an ID number, the name of the server which deposited it and, in some cases, an expiry date. We use cookies to record information about your visit, language of preference, and other parameters on the site in order to optimise your next visit and make the site even more useful to you.

To improve your experience, we use cookies to store certain browsing information and provide secure navigation, and to collect statistics with a view to improve the site’s features. For a complete list of the cookies we use, download “Ghostery”, a free plug-in for browsers which can detect, and, in some cases, block cookies.

Ghostery is available here for free: https://www.ghostery.com/fr/products/

You can also visit the CNIL web site for instructions on how to configure your browser to manage cookie storage on your device.

In the case of third-party advertising cookies, you can also visit the following site: http://www.youronlinechoices.com/fr/controler-ses-cookies/, offered by digital advertising professionals within the European Digital Advertising Alliance (EDAA). From the site, you can deny or accept the cookies used by advertising professionals who are members.

It is also possible to block certain third-party cookies directly via publishers:

Cookie type

Means of blocking

Analytical and performance cookies

Realytics
Google Analytics
Spoteffects
Optimizely

Targeted advertising cookies

DoubleClick
Mediarithmics

The following types of cookies may be used on our websites:

Mandatory cookies

Functional cookies

Social media and advertising cookies

These cookies are needed to ensure the proper functioning of the site and cannot be disabled. They help ensure a secure connection and the basic availability of our website.

These cookies allow us to analyse site use in order to measure and optimise performance. They allow us to store your sign-in information and display the different components of our website in a more coherent way.

These cookies are used by advertising agencies such as Google and by social media sites such as LinkedIn and Facebook. Among other things, they allow pages to be shared on social media, the posting of comments, and the publication (on our site or elsewhere) of ads that reflect your centres of interest.

Our EZPublish content management system (CMS) uses CAS and PHP session cookies and the New Relic cookie for monitoring purposes (IP, response times).

These cookies are deleted at the end of the browsing session (when you log off or close your browser window)

Our EZPublish content management system (CMS) uses the XiTi cookie to measure traffic. Our service provider is AT Internet. This company stores data (IPs, date and time of access, length of the visit and pages viewed) for six months.

Our EZPublish content management system (CMS) does not use this type of cookie.

For more information about the cookies we use, contact INRA’s Data Protection Officer by email at cil-dpo@inra.fr or by post at:

INRA
24, chemin de Borde Rouge –Auzeville – CS52627
31326 Castanet Tolosan CEDEX - France

Dernière mise à jour : Mai 2018

Menu Logo Principal Logo BIA

Home page

MiBioGate

Microbiota Biological Gate

MicroBiota Biological Gate
Study of biological barriers and their microbiota in the development of chronic diseases, supported by Région Pays de la Loire.

MiBioGate, winner of the call for proposals "scientific dynamics" launched by the Pays de la Loire region, it brings together 11 regional and interregional partners for 5 years.
The purpose of this consortium is to structure a research network specialized in the dysfunction of the biological barriers of different organs in chronic pathologies.

The MiBioGate project aims is to characterize the molecular and phenotypic alterations of epithelial barriers and  cutaneous, intestinal and pulmonary microbiotes during the following pathologies:

  • Allergies / Asthma
  • Liver diseases (Non-alcoholic Fatty Liver Disease)
  • Chronic inflammatory bowel diseases (Crohn's disease and Hemorrhagic Rectocolitis)
  • Diseases of the intestinal-brain axis (neurodevelopmental, neurodegenerative and psychiatric)

The objective is to identify potential therapeutic which act on microbiota (prebiotic, probiotic) or barrier mediators (junction proteins, inflammatory mediators, danger receptors).

Schema MiBioGate

The Allergy team is involved in the study of barrier dysfunctions during food and respiratory allergies. Researchers from the team supervise theses in co-supervision with various academic laboratories in the Pays de la Loire region:

Barrier dysfunction in respiratory/asthma allergies
Supervisor: Pr Antoine Magnan (UMR1087 IT) / Dr Grégory Bouchaud (UMR1268 BIA)

Barrier dysfunction in IDB (Chronic Inflammatory Bowel Diseases) _ Amelie Le
Supervisor: Dr Malvyne Rolli-Derkinderen (UMR1235 TENS) / Dr Marie Bodinier (UMR1268 BIA)

See also

The next event will take place in Nantes on 20 and 21 November

Journée Santé / Microbiote

There will be presentations on:

  • the impact of the microbiota on neurodevelopment and aging
  • microbiota analysis techniques
  • the integration of microbiota analysis results with genomic, physiological or clinical data via a systems biology approach
  • therapeutic tools for modulating the microbiota
  • the communication vectors of the microbiota and its host: example of extracellular vesicles
  • microbiota and metabolic disorders

> Programme <